Our project, DART2OS, has received the prestigious “Emerging Fields” grant by Austrian Science Fund FWF – St. Anna Children’s Cancer Research Institute

Quoting St. Anna Children’s Cancer Research Institute on LinkedIn:

“We are excited to share that our project, DART2OS, has received the prestigious ‘Emerging Fields’ grant by Austrian Science Fund FWF. A heartfelt thank you to FWF for endorsing our commitment to advancing cancer research!

Coordinated by the Institute for Molecular Pathology, DART2OS is at the forefront of pioneering T-cell therapy research aimed at developing new, effective treatments for Osteosarcoma. Our PI Sabine Taschner-Mandl plays a key role in this groundbreaking endeavor, emphasizing our institute’s dedication to transformative cancer research.

DART2OS ‘ objective? To revolutionize the treatment landscape for Osteosarcoma, bringing new hope to patients and families affected by this challenging condition.

Learn more about DART2OS in our press release.”

Source: St. Anna Children’s Cancer Research Institute/LinkedIn